{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T10:30:16Z","timestamp":1784716216133,"version":"3.55.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Soc Psychiatry Psychiatr Epidemiol"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s00127-023-02574-1","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T15:02:33Z","timestamp":1697554953000},"page":"799-811","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Consumption of psychotropic drugs in Croatia before and during the COVID-19 pandemic: a 10-year longitudinal study (2012\u20132021)"],"prefix":"10.1007","volume":"59","author":[{"given":"Tea","family":"Vuki\u0107evi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pero","family":"Dragani\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"\u0160kribulja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Puljak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svjetlana","family":"Do\u0161enovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,17]]},"reference":[{"issue":"12","key":"2574_CR1","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S2215-0366(21)00431-4","volume":"8","author":"L Kola","year":"2021","unstructured":"Kola L (2021) Beyond access to psychotropic medicines: treatment coverage amid COVID-19. The Lancet Psychiatry 8(12):1019\u20131021. https:\/\/doi.org\/10.1016\/S2215-0366(21)00431-4","journal-title":"The Lancet Psychiatry"},{"key":"2574_CR2","unstructured":"World Health Organization (2013) Mental health action plan 2013 \u2013 2020. https:\/\/www.who.int\/publications\/i\/item\/9789241506021. Accessed 12 July 2023"},{"key":"2574_CR3","doi-asserted-by":"publisher","unstructured":"Stimac D, Pavic Simetin I, \u0160tajduhar D, Istvanovic A (2018) Reorientation of mental health care in the Republic of Croatia. Euro J Publ Health 28 (4). https:\/\/doi.org\/10.1093\/eurpub\/cky218.208","DOI":"10.1093\/eurpub\/cky218.208"},{"key":"2574_CR4","unstructured":"Mental well-being and social support statistics (2019) In Health in the European Union (2022). https:\/\/stat.link\/pcxvjy. Accessed Sept 2023"},{"key":"2574_CR5","unstructured":"United Nations Development Programme (2022) Human Development Report 2021\u201322. http:\/\/report.hdr.undp.org. Accessed Sept 2023"},{"issue":"12","key":"2574_CR6","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/S2215-0366(21)00292-3","volume":"8","author":"R Brauer","year":"2021","unstructured":"Brauer R, Alfageh B, Blais JE, Chan EW, Chui CSL, Hayes JF, Man KKC, Lau WCY, Yan VKC, Beykloo MY, Wang Z, Wei L, Wong ICK (2021) Psychotropic medicine consumption in 65 countries and regions, 2008\u201319: a longitudinal study. Lancet Psychiatry 8(12):1071\u20131082. https:\/\/doi.org\/10.1016\/S2215-0366(21)00292-3","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"2574_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0284389","volume":"18","author":"O Alabaku","year":"2023","unstructured":"Alabaku O, Yang A, Tharmarajah S, Suda K, Vigod S, Tadrous M (2023) Global trends in antidepressant, atypical antipsychotic, and benzodiazepine use: a cross-sectional analysis of 64 countries. PLoS ONE 18(4):e0284389. https:\/\/doi.org\/10.1371\/journal.pone.0284389","journal-title":"PLoS ONE"},{"key":"2574_CR8","unstructured":"World Health Organisation. Mental Health and COVID-19: Early evidence of the pandemic\u2019s impact: Scientific brief, 2 March 2022. (2022). https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-Sci_Brief-Mental_health-2022.1. 2022, Dec 19"},{"key":"2574_CR9","doi-asserted-by":"publisher","unstructured":"Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic (2021). Lancet 398 (10312):1700\u20131712. doi:https:\/\/doi.org\/10.1016\/s0140-6736(21)02143-7","DOI":"10.1016\/s0140-6736(21)02143-7"},{"issue":"8","key":"2574_CR10","doi-asserted-by":"publisher","first-page":"4782","DOI":"10.3390\/ijerph19084782","volume":"19","author":"MdC Gonz\u00e1lez-L\u00f3pez","year":"2022","unstructured":"Gonz\u00e1lez-L\u00f3pez MdC, D\u00edaz-Calvo V, Ru\u00edz-Gonz\u00e1lez C, Nievas-Soriano BJ, Rebollo-Lavado B, Parr\u00f3n-Carre\u00f1o T (2022) Consumption of psychiatric drugs in primary care during the COVID-19 pandemic. Int J Environ Res Publ Health 19(8):4782","journal-title":"Int J Environ Res Publ Health"},{"key":"2574_CR11","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jad.2022.11.068","volume":"323","author":"M Tiger","year":"2023","unstructured":"Tiger M, Wesselhoeft R, Karlsson P, Handal M, Bliddal M, Cesta CE, Skurtveit S, Reutfors J (2023) Utilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemic in Scandinavia. J Affect Disord 323:292\u2013298. https:\/\/doi.org\/10.1016\/j.jad.2022.11.068","journal-title":"J Affect Disord"},{"issue":"1","key":"2574_CR12","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1186\/s12889-023-15360-0","volume":"23","author":"MLN Garcia","year":"2023","unstructured":"Garcia MLN, Martinez PF, Breton EF, Martinez Alfonso MM, Gil PS (2023) Psychotropic consumption before and during COVID-19 in Asturias. Spain BMC public health 23(1):494. https:\/\/doi.org\/10.1186\/s12889-023-15360-0","journal-title":"Spain BMC public health"},{"issue":"1","key":"2574_CR13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s40199-021-00390-z","volume":"29","author":"SA Rabeea","year":"2021","unstructured":"Rabeea SA, Merchant HA, Khan MU, Kow CS, Hasan SS (2021) Surging trends in prescriptions and costs of antidepressants in England amid COVID-19. Daru 29(1):217\u2013221. https:\/\/doi.org\/10.1007\/s40199-021-00390-z","journal-title":"Daru"},{"key":"2574_CR14","doi-asserted-by":"publisher","first-page":"1131357","DOI":"10.3389\/fphar.2023.1131357","volume":"14","author":"FS Del Fiol","year":"2023","unstructured":"Del Fiol FS, Bergamaschi CC, Lopes LC, Silva MT, Barberato-Filho S (2023) Sales trends of psychotropic drugs in the COVID-19 pandemic: a national database study in Brazil. Front Pharmacol 14:1131357. https:\/\/doi.org\/10.3389\/fphar.2023.1131357","journal-title":"Front Pharmacol"},{"issue":"4","key":"2574_CR15","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1136\/jech-2021-216732","volume":"76","author":"M Estrela","year":"2022","unstructured":"Estrela M, Silva TM, Gomes ER, Pineiro M, Figueiras A, Roque F, Herdeiro MT (2022) Prescription of anxiolytics, sedatives, hypnotics and antidepressants in outpatient, universal care during the COVID-19 pandemic in Portugal: a nationwide, interrupted time-series approach. J Epidemiol Community Health 76(4):335\u2013340. https:\/\/doi.org\/10.1136\/jech-2021-216732","journal-title":"J Epidemiol Community Health"},{"issue":"7624","key":"2574_CR16","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"E Ev","year":"2007","unstructured":"Ev E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP (2007) Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335(7624):806\u2013808. https:\/\/doi.org\/10.1136\/bmj.39335.541782.AD","journal-title":"BMJ"},{"key":"2574_CR17","unstructured":"Ordinance on the type of data and manner of drafting the report on medicinal product consumption. Republic of Croatia, Ministry of Health. (2014). https:\/\/www.halmed.hr\/fdsak3jnFsk1Kfa\/zakoni\/Ordinance-on-the-Type-of-Data-and-Manner-of-Drafting-the-Report-on-Medicinal-Product-Consumption-eng_m-21-en.pdf. Accessed September 2023"},{"key":"2574_CR18","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. ATC\/DDD Index (2023) https:\/\/www.whocc.no\/atc_ddd_index\/?code=N&showdescription=yes. Accessed 12 July 2023"},{"key":"2574_CR19","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. International language for drug utilization research (2023). https:\/\/www.whocc.no\/. Accessed 12 July 2023"},{"key":"2574_CR20","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. Definition and general considerations (2023). https:\/\/www.whocc.no\/ddd\/definition_and_general_considera\/. Accessed 12 July 2023"},{"issue":"1","key":"2574_CR21","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12874-021-01306-w","volume":"21","author":"SL Turner","year":"2021","unstructured":"Turner SL, Karahalios A, Forbes AB, Taljaard M, Grimshaw JM, McKenzie JE (2021) Comparison of six statistical methods for interrupted time series studies: empirical evaluation of 190 published series. BMC Med Res Methodol 21(1):134. https:\/\/doi.org\/10.1186\/s12874-021-01306-w","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"2574_CR22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12874-021-01235-8","volume":"21","author":"AL Schaffer","year":"2021","unstructured":"Schaffer AL, Dobbins TA, Pearson SA (2021) Interrupted time series analysis using autoregressive integrated moving average (ARIMA) models: a guide for evaluating large-scale health interventions. BMC Med Res Methodol 21(1):58. https:\/\/doi.org\/10.1186\/s12874-021-01235-8","journal-title":"BMC Med Res Methodol"},{"issue":"8","key":"2574_CR23","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1017\/S0033291711002558","volume":"42","author":"S Evans-Lacko","year":"2012","unstructured":"Evans-Lacko S, Brohan E, Mojtabai R, Thornicroft G (2012) Association between public views of mental illness and self-stigma among individuals with mental illness in 14 European countries. Psychol Med 42(8):1741\u20131752. https:\/\/doi.org\/10.1017\/S0033291711002558","journal-title":"Psychol Med"},{"issue":"10","key":"2574_CR24","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.euroneuro.2017.07.001","volume":"27","author":"O Halfdanarson","year":"2017","unstructured":"Halfdanarson O, Zoega H, Aagaard L, Bernardo M, Brandt L, Fuste AC, Furu K, Garuoliene K, Hoffmann F, Huybrechts KF, Kalverdijk LJ, Kawakami K, Kieler H, Kinoshita T, Litchfield M, Lopez SC, Machado-Alba JE, Machado-Duque ME, Mahesri M, Nishtala PS, Pearson SA, Reutfors J, Saastamoinen LK, Sato I, Schuiling-Veninga CCM, Shyu YC, Skurtveit S, Verdoux H, Wang LJ, Yahni CZ, Bachmann CJ (2017) International trends in antipsychotic use: a study in 16 countries, 2005\u20132014. Eur Neuropsychopharmacol 27(10):1064\u20131076. https:\/\/doi.org\/10.1016\/j.euroneuro.2017.07.001","journal-title":"Eur Neuropsychopharmacol"},{"key":"2574_CR25","unstructured":"Arana GW (2000) An overview of side effects caused by typical antipsychotics. J Clin Psychiatry 61 Suppl 8:5\u201311; discussion 12\u201313"},{"key":"2574_CR26","doi-asserted-by":"publisher","unstructured":"Crossley NA, Constante M, McGuire P, Power P (2010) Efficacy of atypical v. typical antipsychotics in the treatment of early psychosis: meta-analysis. Br J Psychiatry 196 (6):434\u2013439. https:\/\/doi.org\/10.1192\/bjp.bp.109.066217","DOI":"10.1192\/bjp.bp.109.066217"},{"issue":"10","key":"2574_CR27","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s40266-014-0205-1","volume":"31","author":"HC Ndukwe","year":"2014","unstructured":"Ndukwe HC, Tordoff JM, Wang T, Nishtala PS (2014) Psychotropic medicine utilization in older people in New Zealand from 2005 to 2013. Drugs Aging 31(10):755\u2013768. https:\/\/doi.org\/10.1007\/s40266-014-0205-1","journal-title":"Drugs Aging"},{"key":"2574_CR28","unstructured":"Jakovljevic M (2009) New generation vs. first generation antipsychotics debate: pragmatic clinical trials and practice-based evidence. Psychiatr Danub 21 (4):446\u2013452"},{"issue":"7","key":"2574_CR29","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1111\/bcp.13945","volume":"85","author":"M Hojlund","year":"2019","unstructured":"Hojlund M, Pottegard A, Johnsen E, Kroken RA, Reutfors J, Munk-Jorgensen P, Correll CU (2019) Trends in utilization and dosing of antipsychotic drugs in Scandinavia: comparison of 2006 and 2016. Br J Clin Pharmacol 85(7):1598\u20131606. https:\/\/doi.org\/10.1111\/bcp.13945","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"2574_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-006135","volume":"4","author":"L Marston","year":"2014","unstructured":"Marston L, Nazareth I, Petersen I, Walters K, Osborn DP (2014) Prescribing of antipsychotics in UK primary care: a cohort study. BMJ Open 4(12):e006135. https:\/\/doi.org\/10.1136\/bmjopen-2014-006135","journal-title":"BMJ Open"},{"issue":"4","key":"2574_CR31","doi-asserted-by":"publisher","first-page":"E225","DOI":"10.9778\/cmajo.20140009","volume":"2","author":"T Pringsheim","year":"2014","unstructured":"Pringsheim T, Gardner DM (2014) Dispensed prescriptions for quetiapine and other second-generation antipsychotics in Canada from 2005 to 2012: a descriptive study. CMAJ Open 2(4):E225-232. https:\/\/doi.org\/10.9778\/cmajo.20140009","journal-title":"CMAJ Open"},{"issue":"1","key":"2574_CR32","doi-asserted-by":"publisher","first-page":"6912","DOI":"10.1038\/s41598-023-33765-0","volume":"13","author":"L Madeira","year":"2023","unstructured":"Madeira L, Queiroz G, Henriques R (2023) Prepandemic psychotropic drug status in Portugal: a nationwide pharmacoepidemiological profile. Sci Rep 13(1):6912. https:\/\/doi.org\/10.1038\/s41598-023-33765-0","journal-title":"Sci Rep"},{"issue":"5","key":"2574_CR33","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2165\/11632030-000000000-00000","volume":"26","author":"A McKean","year":"2012","unstructured":"McKean A, Monasterio E (2012) Off-label use of atypical antipsychotics: cause for concern? CNS Drugs 26(5):383\u2013390. https:\/\/doi.org\/10.2165\/11632030-000000000-00000","journal-title":"CNS Drugs"},{"issue":"10","key":"2574_CR34","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1007\/s00228-018-2498-1","volume":"74","author":"ELA Ribeiro","year":"2018","unstructured":"Ribeiro ELA, de Mendonca LT, Vieira MEB, Storpirtis S, Aguiar PM (2018) Efficacy and safety of aripiprazole for the treatment of schizophrenia: an overview of systematic reviews. Eur J Clin Pharmacol 74(10):1215\u20131233. https:\/\/doi.org\/10.1007\/s00228-018-2498-1","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"2574_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41537-021-00158-z","volume":"7","author":"DD Kim","year":"2021","unstructured":"Kim DD, Barr AM, Lian L, Yuen JWY, Fredrikson D, Honer WG, Thornton AE, Procyshyn RM (2021) Efficacy and tolerability of aripiprazole versus D(2) antagonists in the early course of schizophrenia: a systematic review and meta-analysis. NPJ Schizophr 7(1):29. https:\/\/doi.org\/10.1038\/s41537-021-00158-z","journal-title":"NPJ Schizophr"},{"issue":"Suppl 5","key":"2574_CR36","first-page":"750","volume":"31","author":"SZ Markovic","year":"2019","unstructured":"Markovic SZ, Dimitrijevic Jovanovic NI, Sedic B, Vukovic MH, Okjan JJ, Dimitrijevic IK, Trikos LD, Mojovic MD, Kastratovic DA (2019) Impact of Differences in economic development and socioeconomic stability on benzodiazepine exposure between the three Balkans countries. Psychiatr Danub 31(Suppl 5):750\u2013760","journal-title":"Psychiatr Danub"},{"key":"2574_CR37","doi-asserted-by":"publisher","unstructured":"Guina J, Merrill B (2018) Benzodiazepines I: upping the care on downers: the evidence of risks, benefits and alternatives. J Clin Med 7 (2). https:\/\/doi.org\/10.3390\/jcm7020017","DOI":"10.3390\/jcm7020017"},{"issue":"6","key":"2574_CR38","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1007\/s11096-019-00915-2","volume":"41","author":"M Delas Azdajic","year":"2019","unstructured":"Delas Azdajic M, Likic R, Azdajic S, Situm M, Lovric I, Stimac Grbic D (2019) Outpatient benzodiazepine utilization in Croatia: drug use or misuse. Int J Clin Pharm 41(6):1526\u20131535. https:\/\/doi.org\/10.1007\/s11096-019-00915-2","journal-title":"Int J Clin Pharm"},{"issue":"2","key":"2574_CR39","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00127-021-02147-0","volume":"57","author":"Y Okada","year":"2022","unstructured":"Okada Y, Akazawa M (2022) Effects of medical service fee revision on reducing irrational psychotropic polypharmacy in Japan: an interrupted time-series analysis. Soc Psychiatry Psychiatric Epidemiol 57(2):411\u2013422. https:\/\/doi.org\/10.1007\/s00127-021-02147-0","journal-title":"Soc Psychiatry Psychiatric Epidemiol"},{"key":"2574_CR40","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsad124","author":"TT Ma","year":"2023","unstructured":"Ma TT, Wang Z, Qin X, Ju C, Lau WCY, Man KKC, Castle D, Chang WC, Chan AYL, Cheung ECL, Chui CSL, Wong ICK (2023) Global trends in the consumption of benzodiazepines and Z-drugs in 67 countries and regions from 2008\u20132018: a sales data analysis. Sleep. https:\/\/doi.org\/10.1093\/sleep\/zsad124","journal-title":"Sleep"},{"issue":"6","key":"2574_CR41","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1111\/bcp.13570","volume":"84","author":"CA Cadogan","year":"2018","unstructured":"Cadogan CA, Ryan C, Cahir C, Bradley CP, Bennett K (2018) Benzodiazepine and Z-drug prescribing in Ireland: analysis of national prescribing trends from 2005 to 2015. Br J Clin Pharmacol 84(6):1354\u20131363. https:\/\/doi.org\/10.1111\/bcp.13570","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"2574_CR42","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.22374\/1710-6222.26.1.3","volume":"26","author":"J Brandt","year":"2019","unstructured":"Brandt J, Alessi-Severini S, Singer A, Leong C (2019) Novel Measures of benzodiazepine and Z-drug utilisation trends in a canadian provincial adult population (2001\u20132016). J Popul Ther Clin Pharmacol 26(1):e22\u2013e38. https:\/\/doi.org\/10.22374\/1710-6222.26.1.3","journal-title":"J Popul Ther Clin Pharmacol"},{"key":"2574_CR43","unstructured":"Agency for Medicinal Products and Medical Devices of Croatia (HALMED) (2014) News March 2014. https:\/\/www.halmed.hr\/en\/Novosti-i-edukacije\/Novosti\/2014\/PRAC-News-%E2%80%93March-2014\/1040. Accessed Sept 2023"},{"issue":"10","key":"2574_CR44","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1046\/j.1360-0443.2003.00491.x","volume":"98","author":"G Hajak","year":"2003","unstructured":"Hajak G, M\u00fcller WE, Wittchen HU, Pittrow D, Kirch W (2003) Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction 98(10):1371\u20131378. https:\/\/doi.org\/10.1046\/j.1360-0443.2003.00491.x","journal-title":"Addiction"},{"issue":"0304","key":"2574_CR45","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2013.13745","volume":"143","author":"F Hoffmann","year":"2013","unstructured":"Hoffmann F (2013) Perceptions of German GPs on benefits and risks of benzodiazepines and Z-drugs. Swiss Med Wkly 143(0304):w13745. https:\/\/doi.org\/10.4414\/smw.2013.13745","journal-title":"Swiss Med Wkly"},{"issue":"10","key":"2574_CR46","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1177\/0004867417721018","volume":"51","author":"J Brett","year":"2017","unstructured":"Brett J, Karanges EA, Daniels B, Buckley NA, Schneider C, Nassir A, Zoega H, McLachlan AJ, Pearson SA (2017) Psychotropic medication use in Australia, 2007 to 2015: changes in annual incidence, prevalence and treatment exposure. Aust N Z J Psychiatry 51(10):990\u2013999. https:\/\/doi.org\/10.1177\/0004867417721018","journal-title":"Aust N Z J Psychiatry"},{"issue":"10","key":"2574_CR47","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1177\/0004867414538675","volume":"48","author":"EA Karanges","year":"2014","unstructured":"Karanges EA, Stephenson CP, McGregor IS (2014) Longitudinal trends in the dispensing of psychotropic medications in Australia from 2009\u20132012: focus on children, adolescents and prescriber specialty. Aust N Z J Psychiatry 48(10):917\u2013931. https:\/\/doi.org\/10.1177\/0004867414538675","journal-title":"Aust N Z J Psychiatry"},{"issue":"2","key":"2574_CR48","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/j.1472-8206.2010.00906.x","volume":"26","author":"F Rouby","year":"2012","unstructured":"Rouby F, Pradel V, Frauger E, Pauly V, Natali F, Reggio P, Thirion X, Micallef J (2012) Assessment of abuse of tianeptine from a reimbursement database using \u201cdoctor-shopping\u201d as an indicator. Fundam Clin Pharmacol 26(2):286\u2013294. https:\/\/doi.org\/10.1111\/j.1472-8206.2010.00906.x","journal-title":"Fundam Clin Pharmacol"},{"issue":"3","key":"2574_CR49","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/02791072.2018.1438687","volume":"50","author":"J Springer","year":"2018","unstructured":"Springer J, Cuba\u0142a WJ (2018) Tianeptine abuse and dependence in psychiatric patients: a review of 18 case reports in the literature. J Psychoactive Drugs 50(3):275\u2013280. https:\/\/doi.org\/10.1080\/02791072.2018.1438687","journal-title":"J Psychoactive Drugs"},{"issue":"3","key":"2574_CR50","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.pnpbp.2007.01.002","volume":"31","author":"C Kisa","year":"2007","unstructured":"Kisa C, Bulbul DO, Aydemir C, Goka E (2007) Is it possible to be dependent to Tianeptine, an antidepressant? A case report. Progress Neuro-Psychopharmacol Biol Psychiatry 31(3):776\u2013778. https:\/\/doi.org\/10.1016\/j.pnpbp.2007.01.002","journal-title":"Progress Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"6","key":"2574_CR51","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.psym.2018.07.006","volume":"59","author":"R Lauhan","year":"2018","unstructured":"Lauhan R, Hsu A, Alam A, Beizai K (2018) Tianeptine abuse and dependence: case report and literature review. Psychosomatics 59(6):547\u2013553. https:\/\/doi.org\/10.1016\/j.psym.2018.07.006","journal-title":"Psychosomatics"},{"key":"2574_CR52","unstructured":"European Medicines Agency (EMA) (2014) Tianeptine: CMDh scientific conclusions and grounds for the variation, amendments to the product information and timetable for the implementation. https:\/\/www.ema.europa.eu\/en\/documents\/psusa\/tianeptine-cmdh-scientific-conclusions-amendments-product-information-implementation-timetable-psusa\/00002943\/201806_en.pdf. Accessed Sept 2023"},{"key":"2574_CR53","unstructured":"Croatian Farmaceutical Society (2020) Important information about prescribing medicines during the COVID-19 pandemic (Va\u017ene obavijesti o propisivanju i izdavanju lijekova u vrijeme epidemije COVID-19). https:\/\/farmaceut.org\/vazne-obavijesti-o-propisivanju-i-izdavanju-lijekova-u-vrijeme-epidemije-covid-19\/. Accessed Sept 2023"},{"key":"2574_CR54","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.euroneuro.2023.04.004","volume":"73","author":"A Laurin","year":"2023","unstructured":"Laurin A, Bulteau S, Caillet P, Artari P, Sauvaget A, Gollier-Briant F, Huon J-F, Bonnot O (2023) Psychotropic drugs consumption during 2020 COVID-19 pandemic and lockdowns: evidence of a surprising resilience of the drugs delivery system in France. Eur Neuropsychopharm 73:48\u201361. https:\/\/doi.org\/10.1016\/j.euroneuro.2023.04.004","journal-title":"Eur Neuropsychopharm"},{"key":"2574_CR55","doi-asserted-by":"publisher","unstructured":"Heald A, Stedman M, Farman S, Ruzhdi N, Davies M, Taylor D (2021) Seasonal Variation in Antidepressant Prescribing: Year on Year Analysis for England. Prim Care Companion CNS Disord 23 (2). https:\/\/doi.org\/10.4088\/PCC.20m02790","DOI":"10.4088\/PCC.20m02790"},{"issue":"2","key":"2574_CR56","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1192\/bjp.2019.40","volume":"215","author":"T Lansdall-Welfare","year":"2019","unstructured":"Lansdall-Welfare T, Lightman S, Cristianini N (2019) Seasonal variation in antidepressant prescriptions, environmental light and web queries for seasonal affective disorder. Br J Psychiatry 215(2):481\u2013484. https:\/\/doi.org\/10.1192\/bjp.2019.40","journal-title":"Br J Psychiatry"},{"key":"2574_CR57","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jpsychires.2019.01.020","volume":"111","author":"D Winkler","year":"2019","unstructured":"Winkler D, Reichardt B, Kranz GS, Bartova L, Kasper S, Pjrek E (2019) Seasonality of antidepressant prescriptions and sick leaves. J Psychiatr Res 111:128\u2013133. https:\/\/doi.org\/10.1016\/j.jpsychires.2019.01.020","journal-title":"J Psychiatr Res"},{"issue":"14","key":"2574_CR58","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1177\/1087054714523129","volume":"21","author":"\u00d6 \u00d6ner","year":"2017","unstructured":"\u00d6ner \u00d6, Yilmaz E, Karada\u011f H, Vural M, Vural EH, Akbulat A, G\u00fcrs\u00f6z H, T\u00fcrk\u00e7apar H, Kerman S (2017) ADHD medication trends in Turkey: 2009\u20132013. J Atten Disord 21(14):1192\u20131197. https:\/\/doi.org\/10.1177\/1087054714523129","journal-title":"J Atten Disord"},{"issue":"3","key":"2574_CR59","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.clinthera.2016.01.015","volume":"38","author":"YC Shyu","year":"2016","unstructured":"Shyu YC, Lee SY, Yuan SS, Yang CJ, Yang KC, Lee TL, Wang LJ (2016) Seasonal patterns of medications for treating attention-deficit\/hyperactivity disorder: comparison of methylphenidate and atomoxetine. Clin Ther 38(3):595\u2013602. https:\/\/doi.org\/10.1016\/j.clinthera.2016.01.015","journal-title":"Clin Ther"},{"key":"2574_CR60","doi-asserted-by":"publisher","first-page":"S283","DOI":"10.1016\/j.eurpsy.2017.02.134","volume":"41","author":"IP Gradi\u0161ki","year":"2017","unstructured":"Gradi\u0161ki IP, Bili\u0107 P, Sabo T, Vilibi\u0107 M (2017) Tracking insomnia seasonal variations through consumption of hypnotics. Eur Psychiatry 41:S283. https:\/\/doi.org\/10.1016\/j.eurpsy.2017.02.134","journal-title":"Eur Psychiatry"},{"issue":"1","key":"2574_CR61","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1038\/s41467-021-22944-0","volume":"12","author":"C Modi","year":"2021","unstructured":"Modi C, B\u00f6hm V, Ferraro S, Stein G, Seljak U (2021) Estimating COVID-19 mortality in Italy early in the COVID-19 pandemic. Nat Commun 12(1):2729. https:\/\/doi.org\/10.1038\/s41467-021-22944-0","journal-title":"Nat Commun"}],"container-title":["Social Psychiatry and Psychiatric Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00127-023-02574-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00127-023-02574-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00127-023-02574-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T06:05:39Z","timestamp":1715321139000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00127-023-02574-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,17]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["2574"],"URL":"https:\/\/doi.org\/10.1007\/s00127-023-02574-1","relation":{},"ISSN":["0933-7954","1433-9285"],"issn-type":[{"value":"0933-7954","type":"print"},{"value":"1433-9285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,17]]},"assertion":[{"value":"31 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}